New hope for transplant patients: could a simple infusion stop a dangerous virus?
Disease control
Recruiting now
This study tests whether giving an extra medicine (CMV immunoglobulin) after standard antiviral treatment can prevent late CMV infection in high-risk kidney and liver transplant recipients. About 80 adults who are at high risk because their donor had CMV but they did not will rec…
Phase: PHASE4 • Sponsor: Camille N. Kotton, MD • Aim: Disease control
Last updated May 17, 2026 03:57 UTC